Haseena Ismail

National Assembly

Write a public message to this MP

@haseenada1

About Haseena Ismail

2021 committee attendance as mp

100% attendance rate

Attended 16 meetings out of 16

2020 committee attendance as mp

83% attendance rate

Attended 19 meetings out of 23

2019 committee attendance as mp

100% attendance rate

Attended 1 meeting out of 1

Attendance Methodology

Recent meetings attended

Health — Update on NHI parliamentary process; COVID-19 vaccine procurement and roll-out update; with Minister & Deputy Minister — 30 Mar 2021
Health — SAMRC on Johnson & Johnson clinical trial & 2019/20 Annual Report; Parliament's TB Caucus — 24 Mar 2021
Health — South African Health Products Regulatory Authority 2019/20 Annual Report — 17 Mar 2021
Health — National Health Laboratory Services 2019/20 Annual Report; National Health Amendment Bill: rejection — 10 Mar 2021
Health — Department of Health update on vaccine rollout; with Deputy Minister — 5 Mar 2021

All meetings attended

DISCLAIMER: This information has been obtained via the Parliamentary Monitoring Group. PMG makes every effort to compile reliable and comprehensive information, but does not claim that the data is 100% accurate and complete.

Currently

Member at Joint Committee on South African chapter of Global TC Caucus (Joint Committees) since 17th March 2020
Alternate Member at Portfolio Committee on Health (National Assembly Committees) since 27th June 2019
Member at National Assembly (Parliament) since 22nd May 2019
Member at Democratic Alliance (DA) (Party)

Formerly

3rd Candidate at Democratic Alliance Regional Gauteng Election List 2019 (Election List) from 23rd April 2019 until 8th May 2019
13rd Candidate at Democratic Alliance National Election List 2019 (Election List) from 23rd April 2019 until 8th May 2019

Fetching the latest messages to Haseena Ismail…

Committee appearances

Minister on Johnson & Johnson clinical trials, vaccines procurement & progress roll-out programme 30 Mar 2021

Ms H Ismail (DA) agreed with other Members that there should be no oversight visits during the constituency period, but that fortnightly meetings with the Minister and with SAHPRA were important and should continue, given the COVID-19 situation. She agreed that a programme should be designed so that, after the ...
MRC on Johnson and Johnson Clinical Trials & 2019/20 Annual Report; South African TB Caucus Secretariat on activities to date 24 Mar 2021

Ms H Ismail (DA) said that COVID-19 exposed how quickly, with required focus and resources, a vaccine can actually be developed. How will SAMRC use this experience to develop vaccines for other critical diseases, such as HIV, tuberculosis (TB), malaria and others? Given the economic situation locally and globally, how ...
South African Health Products Regulatory Authority 2019/20 Annual Report; Update on NHI processes 17 Mar 2021

Ms H Ismail (DA) asked what the requirements were that were necessary for Ivermectin to be more readily available to the public. How much data had SAHPRA gathered regarding the effects of Ivermectin? It was a conflict of interest that SAHPRA was receiving funding by institutions, such as the Bill ...
National Health Laboratory Services 2019/20 Annual Report; National Health Amendment Bill: motion of desirability 10 Mar 2021

Ms H Ismail (DA) asked for clarity on how many laboratories were currently functional in each province, and whether each laboratory had sufficient equipment and personnel. How many vacancies for epidemiologists were there currently within the NHLS per province? What measures were being taken to ensure that these vacancies were ...
Minister of Health update on vaccine roll-out 5 Mar 2021

Ms H Ismail (DA) asked where the local production component of Johnson & Johnson was.

All Committee Appearances

Questions

Questions asked to the Minister of Health 11 Mar 2021

Whether, in light of the fact that new vaccines are additionally contaminated with aluminium, mercury and possibly formaldehyde, his department has ensured that the manufacturers of the vaccines disclose what other toxins they contain; if not, why not; if so, what are the relevant details?
Questions asked to the Minister of Health 11 Mar 2021

(1)(a) Whether he will furnish Ms H Ismail with a list of all the additional sites that are being used to administer the vaccines; (2) what are the reasons that children are not prioritised in the vaccine roll-out plan; (3) whether he has found that the vaccines that have already ...
Questions asked to the Minister of Health 11 Mar 2021

Whether any long-term safety studies have been done to ensure that the vaccines do not cause (a) cancer, (b) seizures, (c) heart disease, (d) allergies and (e) autoimmune diseases seen with other vaccines; if not, why not; if so, what are the relevant details?

All Questions and Answers

Plenary appearances

CHARLIZE THERON WINS THE HOLLYWOOD CAREER ACHIEVEMENT AWARD AT THE 23RD ANNUAL HOLLYWOOD FILM AWARDS (Draft Resolution) 12 Nov 2019

House Chairperson, I move without notice:
That the House-
1) notes that Ms Charlize Theron won the Hollywood Career Achievement Award at the 23rd Annual Hollywood Film Awards held in Los Angeles on 3 November 2019;
2) also notes that Ms Theron was born on 7 August 1975 in Benoni, ...
CRIME SITUATION IN ACTONVILLE (Draft Resolution) 24 Oct 2019

Chair, I move without notice:
That the House-
1) notes that the crime situation in Actonville in the City of Ekurhuleni has reached dire levels;
2) further notes that businesses and residents are living in fear due to an alarming increase in the number of occurrences of murders, house and ...

All Plenary Appearances

Correct this page